KRT18 and prostate carcinoma: Consistent with the results of breast cancer patients, four out of five prostate cancer patients had CK18+ mDTCs and one in thesefour4 patients had CK18− mDTCs, while all five prostate cancer patients had CK18− pCTCs and only two had CK18+ pCTCs (Figure 2d).